Brand-name drugs used to treat cardiovascular disease are no better than generics, a new review of available evidence shows.
Yet a number of editorials in medical journals, written by specialists, have urged against substituting the less expensive generics for their designer counterparts.
Generic Heart Drugs as Good as Brand-Name Counterparts
Authorities in France have placed more than a third of the country under a red heat...
One morning early last July, Micha Bitsinnie arrived at work to an onslaught of messages from...
